Reagent Kit Xpert® Molecular Diagnostic C. Difficile / Epi For GeneXpert DX System 10 Tests

Higher risk of cross contamination with 027/NAP1/BI strain due to more efficient sporulation

027/NAP1/BI strain has been identified as a cause of outbreaks around the world

Incremental costs due to C. difficile infection can be as high as $7,1799 per patient

Xpert C. difficile/Epi is the first commercially available test in the world to detect and differentiate the epidemic strain of C. difficile (027/NAP1/BI). With rapid and accurate identification of the epidemic strain, Infection control professional can stay ahead of potential outbreak

Innovative multiplex design enables detection of C. difficile Infection (CDI) and 027/NAP1/BI strain call-out in a single cartridge

On-demand testing of samples from suspected CDI patients provides on-demand epidemiological surveillance data clinicians can act on

Monitoring and reporting of the epidemic strain enables clinicians to improve infection control efforts

Cepheid’s Xpert C. difficile/Epi test provides on demand results you can trust and empowers your clinical team to better manage patients